Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
BPC-157 focuses on protective and vascular pathways, while TB-500 is studied for cell migration and tissue regeneration
References: Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., & Bock-Marquette, I
Uses & Indication Overweight or obesity (BMI above 25) Visceral and abdominal fat reduction Metabolic slowdown associated with aging Enhancing fat loss while maintaining muscle mass Suitable for patients who cannot tolerate stimulant-based weight loss medications Can be used alongside GLP-1 medications but does not replace them Benefits Increases fat breakdown through lipolysis activation Reduces new fat formation Targets stubborn adipose tissue Does not affect blood sugar or IGF-1 levels Safe metabolic profile suitable for long-term use Supports gradual and steady fat loss Dosage & Injection Protocol Standard Dosing 500 mcg subcutaneously once daily Administer in the morning while fasting or before bed Avoid injecting within 2 hours of meals, especially carbohydrate-heavy meals Injection Timing Rules Local injection site irritation (improves with rotation) Mild headache Slight increase in hunger Temporary fatigue Get in Touch Contact Us To Get Better Information
Molecular Neurobiology, 14(3), 117-142
Simultaneously, the activation of the PI3K/Akt pathway leads to the phosphorylation and activation of endothelial Nitric Oxide Synthase (eNOS)
Tirzepatide (Zepbound and Mounjaro): Weekly GLP-1/GIP injection Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics the activity of two natural hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, that regulate your appetite and metabolism
US$ 21.66
US$ 27.27
US$ 24.32
US$ 20.05
US$ 22.45
